In a remarkable continuation of market strength, U.S. equity markets concluded 2025 with an unprecedented third consecutive year of double-digit gains. This sustained upward trajectory, reminiscent of the late 1990s dot-com boom, was primarily fueled by robust corporate profitability and the accelerating momentum of artificial intelligence. However, not all investment vehicles mirrored this broad market success, as the Virtus Zevenbergen Innovative Growth Stock Fund recorded a notable underperformance in the fourth quarter.
Virtus Zevenbergen Fund Navigates Dynamic Market Landscape in Q4 2025
The fourth quarter of 2025 saw a fascinating divergence in investment outcomes. While the broader U.S. equity markets continued their impressive winning streak, driven by solid corporate earnings and the persistent enthusiasm surrounding artificial intelligence, the Virtus Zevenbergen Innovative Growth Stock Fund experienced a more challenging period. During this time, the fund, specifically its Class I shares, delivered a return of -2.74%, significantly trailing the Russell 3000 Growth Index's 1.14% gain. This performance gap highlights the nuanced realities of active fund management within a highly concentrated market.
Drilling down into the fund's specific holdings, Exact Sciences and Natera emerged as the primary catalysts for positive contributions during the quarter. These companies, likely operating within the dynamic healthcare diagnostics sector, demonstrated resilience and growth, providing a much-needed buffer against broader headwinds. Conversely, Axon Enterprise and MercadoLibre were identified as the largest detractors from the fund's performance. These underperformers may have faced sector-specific challenges, competitive pressures, or shifts in investor sentiment that impacted their stock valuations.
Looking ahead, the Virtus Zevenbergen Innovative Growth Stock Fund is committed to navigating the complexities of the market with a flexible and forward-looking investment approach. Despite the prevailing market concentration, where a few mega-cap technology stocks often dominate index returns, the fund emphasizes an all-cap strategy. This allows for diversified exposure across companies of various sizes, aiming to uncover opportunities beyond the most popular names. Their methodology centers on rigorous, long-term fundamental analysis, a crucial tool for identifying companies with sustainable growth potential, even amidst macro uncertainty and the inherent risks of index concentration.
This quarter's performance underscores the inherent challenges and opportunities within active investment management. While the market's consistent double-digit returns are impressive, they also signal a potentially overheated environment where selective stock picking becomes paramount. The Virtus Zevenbergen Innovative Growth Stock Fund's experience in Q4 2025 serves as a reminder that even in a bull market, careful analysis and strategic positioning are vital for long-term success. Investors should continue to evaluate fund performance not just against benchmarks, but also within the context of their specific investment philosophies and the broader economic landscape.